PubMed · 7708308
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
A Hickey. 1995. DVT: clearing the record.. https://doi.org/10.1097/00152193-199501000-00002
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Heparin-associated thrombocytopenia and thrombosis (Type II HAT), the "white clot syndrome," has not been previously reported as a cause for fulminant hepatic failure after liver transplantation. Thrombocytopenia and the use of heparin are common events in the newly transplanted patient. A man who was transplanted for sclerosing cholangitis, and re-exposed to heparin, is described with thrombocytopenia, thrombosis of all hepatic vessels, and heparin antibodies. Type II HAT is an immune phenomenon that can apparently occur despite T-cell-directed immunosuppression. Suspicion is a key element in establishing diagnosis. We no longer use heparin routinely in liver transplant cases.
Explore the source record for details and available documents.
Explore the source record for details and available documents.